返回
3D Medicines Inc.（01244.HK）价格
01244.HK 股价走势图
3D MEDICINES (01244.HK)
3D Medicines Inc.
HK$5.21
-5.44%
$-0.29
盘中： Jan 20, 11:44:35 HKT
暂无数据Earnings FAQ
01244.HK 最近的每股收益与预期相比如何？
3D Medicines Inc. 01244.HK 上一季度的收入表现如何？
3D Medicines Inc. 的收入预期是多少？
3D Medicines Inc. 的盈利质量评分是多少？
3D Medicines Inc. 何时发布财报？
3D Medicines Inc. 的预期收益是多少？
3D Medicines Inc. 是否超出收益预期？
关键数据
前收盘价
$5.51
开盘价
$5.51
当日区间
$5.16 - $5.51
52周范围
$2.7 - $10.02
交易量
20.0K
平均成交量
331.2K
每股收益（TTM）
-0.77
股息收益率
--
市值
$1.2B
什么是 3D MEDICINES？
3D Medicines, Inc. is an investment holding company, which engages in biopharmaceutical research and development. The company is headquartered in Qingdao, Shandong and currently employs 183 full-time employees. The company went IPO on 2022-12-15. The firm focuses on the discovery, development and commercialization of innovative drugs in the field of cancer chronic disease treatment, and also lays out the field of cancer pain management. The firm has built a complete set of internal R&D systems, and has covered the entire process from drug discovery, preclinical development, clinical trials, and registration. The firm's first marketed drug, Envafolimab, is a subcutaneously injected PD-L1 inhibitor for the treatment of pan-tumor types. The firm also has a number of innovative drug research and development pipelines. The firm primarily operates in the domestic Chinese market.